Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Non-Therapeutic Biomolecules Market Growth in 2025?

The size of the non-therapeutic biomolecules industry has undergone swift expansion in the past few years. Its growth is expected to accelerate from $30.76 billion in 2024 to $34.23 billion in 2025, marking a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this growth during the historical timeline include upsurged investments in research and development (R&D), growing usage in research and diagnostics, heightened awareness and acceptance, strategic alliances and partnerships, and regulatory aid.

What Is the Forecast for the Non-Therapeutic Biomolecules Market Size Through 2029?

Expectations are high for a swift expansion in the non-therapeutic biomolecules market in the subsequent years. The projected size by 2029 is $52.15 billion, with an 11.1% compound annual growth rate (CAGR). Factors contributing to the anticipated growth in the forecast period include the emergence of new market prospects, advancements in data analytics and integration, increased focus on precision medicine, augmented investments in personalized healthcare, and widening application areas. The upcoming period is also expected to witness noteworthy trends such as technological advancements, strategic collaborations, growing use in agriculture, increased involvement in industrial processes, along with increasing customization and personalization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

What are the Key Market Players in Non-Therapeutic Biomolecules Market and How They’re Evolving?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

What Are the Primary Growth Drivers in the Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecules market’s growth is predicted to be fueled by the fast-paced escalation in research and laboratory testing. Laboratory testing, a medical process that involves examining bodily samples like blood or urine to diagnose and monitor diseases and formulate treatment plans, is coupled with research, a method through which novel knowledge is created or current knowledge is innovatively used to generate new insights, theories, and comprehension. Non-therapeutic biomolecules are utilized in laboratory testing to detect the presence or level of a biomarker molecule indicative of disease, thereby enhancing the test’s sensitivity and specificity. For example, in July 2024, as per the data from the National Health Service (NHS), a hospital and healthcare provider based in the UK, diagnostic activity outpaced the pre-pandemic levels in 2023, showcasing a 21% surge in tests conducted in May 2024 in comparison to the previous year. Hence, the accelerated rise in research and laboratory testing appears to be the driving force behind the growth of the non-therapeutic biomolecules market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

What Are the Leading Segments in the Global Non-Therapeutic Biomolecules Industry?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

What Are the Key Market Trends in the Non-Therapeutic Biomolecules Industry?

The trend of product innovation is emerging prominently in the non-therapeutic biomolecules market, with major players engaging in research as well as development for novel product introductions to maintain dominant market positions. For example, BASF SE, a transnational chemical corporation from Germany, entered into a collaboration with Caregen, a biomimetic peptide R&D entity from Korea, in January 2022. Together, they unveiled the Peptovitae series, a range developed via liposome-encapsulation technology designed to extend its dermo-cosmetic offering. This approach offers innovative, distinct resolutions for a variety of skin issues by directing essential nutrients or medications in small bubbles to certain sections of the body using fat, without impacting other zones. The Peptovitae series caters to a greater scope of skin conditions beyond those typically linked to peptide usage, including age indications, skin brightness enhancement, calming dry, itchy skin and skin hydration.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

What Is the Regional Outlook for the Non-Therapeutic Biomolecules Market?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8769

This Report Delivers Insight On:

1. How big is the non-therapeutic biomolecules market, and how is it changing globally?

2. Who are the major companies in the non-therapeutic biomolecules market, and how are they performing?

3. What are the key opportunities and risks in the non-therapeutic biomolecules market right now?

4. Which products or customer segments are growing the most in the non-therapeutic biomolecules market?

5. What factors are helping or slowing down the growth of the non-therapeutic biomolecules market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model